Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of IBI362 in Chinese Overweight and Obese Subjects

X
Trial Profile

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of IBI362 in Chinese Overweight and Obese Subjects

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Jun 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mazdutide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Sponsors Innovent Biologics
  • Most Recent Events

    • 12 Jun 2024 According to an Innovent Biologics media release, results from this study will be presented at the American Diabetes Association's (ADA) 84th Scientific Sessions in Orlando from June 21 -24.
    • 17 Dec 2023 Results (n=248) from part 1 of this trial presented in an Innovent Biologics media release.
    • 17 Dec 2023 According to an Innovent Biologics media release, results (n=248) from part 1 of this study in Chinese patients with overweight or obesity were published in Nature Communications.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top